Bring the product name into the appointment, not just the company name. Ro Sparks means a fixed 55 mg sildenafil / 22 mg tadalafil sublingual preparation. The useful opening question is how that exact prescription would fit your symptoms, previous treatment and other medicines. This review turns the public offer into a set of notes you can take to the clinician.
Availability: Public product listing; individual eligibility and current prescription require confirmation.
The exact product
Start by asking the prescriber to read back the active ingredients and dosage form. Here the decision involves two PDE5 inhibitors in one prescription. A familiar brand can offer several unrelated preparations; an account preference is not the prescription itself. Put the proposed medicine beside anything you already take, including intermittent treatments and supplements. If the names do not match what you expected, settle that discrepancy before interpreting a delivery or price promise.
| Provider | Ro |
|---|---|
| Listed active ingredients | Sildenafil + tadalafil |
| Dosage form | Compounded sublingual drop |
| Regulatory distinction | Compounded preparation; the finished product is not FDA-approved. |
| Source basis | Ro: ED product catalog and plan quantities · Ro: medication pricing · Ro: Sparks product details |
Price, supply and payment
Make two entries in your notes: the advertised figure and the amount that would actually leave your account. The public figure for Ro Sparks is $48 / 4 doses monthly. The table below keeps any verified supply details beside it. A starting price, unit price and monthly equivalent are different kinds of information. Ask about shipping, consultation charges, renewal and what happens to an unused supply if the clinician changes the treatment early.
| Monthly quantities | 4, 6, 8 or 10 allocated doses |
|---|---|
| Monthly charges | $48, $72, $96 or $120 respectively |
| Unit arithmetic | $12 per allocated dose; not a prescribed frequency |
| Timing limitation | Advertised onset is measured after dissolution, not necessarily from placement in the mouth |
What the research can support
One practical way to read research is to name what was tested. The relevant record here is a 180-man trial of daily tadalafil plus as-needed sildenafil, not the Sparks sublingual formula. The unresolved question is controlled finished-product onset and comparative safety. Those distinctions belong in the consultation because a study of an ingredient cannot silently become a promise about this package. Ask what alternatives the prescriber considered and which result would count as a useful improvement for your circumstances.
| Evidence boundary | a 180-man trial of daily tadalafil plus as-needed sildenafil, not the Sparks sublingual formula |
|---|---|
| Not established here | controlled finished-product onset and comparative safety |
| Clinical and regulatory references | EAU: Management of erectile dysfunction · Cui et al. (2015): daily tadalafil with as-needed sildenafil · MedlinePlus: Tadalafil · DailyMed: Tadalafil prescribing information, including section 5.11 · FDA: Compounding and the FDA — questions and answers · MedlinePlus: Sildenafil |
Safety questions for the prescriber
Give safety questions their own place on the page. Ro Sparks should not be added to an existing ED medicine without the prescribing team's instructions. Disclose nitrates, recreational nitrites, riociguat and blood-pressure medicines, together with heart, kidney, liver and eye conditions. A checklist cannot approve a prescription; it helps prevent omissions during the conversation. The additional product-specific issue below deserves an explicit answer.
| Multiple PDE5 inhibitors | Standard tadalafil labeling advises against combining PDE5 inhibitors; individualized rationale and monitoring are needed. |
|---|
Availability and the actual prescription
Before arranging your routine around this offer, confirm that it is available to you. The research record says: Public product listing; individual eligibility and current prescription require confirmation. An older listing or safety document is useful evidence about a formulation but does not establish that a new patient can order it. Ask whether the state, account history, pharmacy or clinical assessment changes the options, and keep the exact name used in the reply.
Refills, changes and cancellation
Decide how to contact the clinical team before the first refill becomes a billing question. Record whether the medicine helped the problem you described, whether you followed its instructions, and what side effects occurred. For Ro Sparks, take this question to the next conversation: “Why is this combination appropriate after reviewing my response to a single medicine?” A message about symptoms and a request to stop shipments are separate tasks. Keep the account confirmation as well as the clinician's treatment instructions.
| Order cancellation | Contact support promptly during processing; shipped orders cannot be canceled or returned. |
|---|---|
| Prescription refunds | Generally final; dispensing errors and rejected treatment requests are separate cases. |
| Renewal notice | Use the cutoff disclosed for the selected subscription; no universal ED deadline was verified. |
| Clinical change | The support article states a response within two business days; not independently measured. |
| Policy sources | Ro: terms of use, payments and subscriptions · Ro Support: canceling an order · Ro Support: return and refund policy |
Compare named products
Use the linked alternatives to compare one concrete feature at a time: active ingredients, dosage form, schedule or full payment. Do not choose the longest ingredient list or the smallest milligram number as a shortcut. If an earlier treatment disappointed you, describe what happened rather than requesting a stronger-sounding brand. A comparison is useful when it improves the question you ask, not when it substitutes for an assessment.
Questions to keep with the offer
Your appointment note can end with three blanks: the exact prescription, the total first payment, and the date or trigger for clinical follow-up. Leave an item unanswered when the public evidence does not settle it. That is more useful than copying a competitor's terms into the gaps. This is documentary research; we have not ordered Ro Sparks, tested its effects or evaluated the clinicians involved.
| Ask about this formula | Why is this combination appropriate after reviewing my response to a single medicine? |
|---|---|
| Ask about the payment | What are the exact quantity, total due now, renewal amount and notice deadline? |
| Ask about a change | Who confirms the medical instructions, pharmacy order and next account charge? |
When to get urgent help
An erection lasting more than four hours or chest pain requires emergency care. Tell the treating clinician what was taken and when.
Sudden hearing or vision loss needs prompt medical attention. Do not wait for an ordinary account-support reply.
Back to all individual product reviews
Sources for this page
Checked October 7, 2026. Company pages support descriptions of advertised offers, not independent claims of clinical quality.
- Ro: ED product catalog and plan quantitiesProvider catalog; individual products, strengths and plan prices
- Ro: terms of use, payments and subscriptionsProvider policy; distinguish general subscription terms from Ro Body terms
- Ro Support: canceling an orderProvider support; processing orders and future shipments
- Ro Support: return and refund policyProvider support; prescription return and refund restrictions
- Ro Support: changing your prescriptionProvider support; clinical changes and follow-up
- EAU: Management of erectile dysfunctionSpecialty guideline; clinical evaluation, treatment, and limited combination evidence
- Cui et al. (2015): daily tadalafil with as-needed sildenafilPrimary clinical study; 180 patients, specific regimen, abstract reviewed via NCBI
- Ro: medication pricingProvider source; advertised plan prices and quantities
- Ro: Sparks product detailsProvider source; compounded formula, subscription pricing, and care process
- NIDDK: Diagnosis of erectile dysfunctionGovernment patient information
- MedlinePlus: TadalafilDrug information; standard tadalafil products
- DailyMed: Tadalafil prescribing information, including section 5.11Prescribing label; not evidence for the 4Play combination
- FDA: Compounding and the FDA — questions and answersGovernment guidance on compounded medications
- MedlinePlus: SildenafilDrug information; standard sildenafil products